English press releases

ABB: Resilient Growth

ZURICH–(BUSINESS WIRE)– FIRST QUARTER HIGHLIGHTS Total orders +3%1, order backlog +6% Base orders +6%, higher in all divisions and regions Revenues +4%, book-to-bill2 1.11x Operational...

ABB Names Peter Voser as Interim CEO; Ulrich Spiesshofer Steps Down

ZURICH–(BUSINESS WIRE)– The Board of Directors of ABB and its CEO Ulrich Spiesshofer (55) have mutually agreed for him to step down from his role,...

Tech for Good – Aruna Wins Alipay-NUS Enterprise Social Innovation Challenge for Using Digital Technology to Raise Incomes of Fishermen

SINGAPORE–(BUSINESS WIRE)– The Alipay-NUS Enterprise Social Innovation Challenge (“Challenge”), jointly launched by Alipay, the world’s leading payment and lifestyle platform, operated by Ant Financial Services...

Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for Nonalcoholic Steatohepatitis

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Gilead Sciences Inc. (Nasdaq: GILD) and insitro announced today that the companies have entered into a...

Samsung Successfully Completes 5nm EUV Development To Allow Greater Area Scaling and Ultra-low Power Benefits

Samsung Electronics makes major strides in EUV-based advanced nodes, including 7nm mass production and 6nm customer tape-out SEOUL, South Korea–(BUSINESS WIRE)– Samsung Electronics Co., Ltd.,...

97% of Gemalto shares have been tendered to the Thales offer

Following the Post-Closing Acceptance Period, which ended yesterday, approximately 97.02% of Gemalto shares have now been tendered to the Thales offer Settlement of Shares tendered...

Boehringer Ingelheim acquires stake in SoundTalks NV, begins pilot programme

• Boehringer Ingelheim plans a pilot programme using the innovative SoundTalksTM system in select pig barns • The goal is to harness the power of...

Independent large real-world study comparing NOACs in AF-patients

A recently published large retrospective comparative study investigated stroke, bleeding and mortality risks in older US Medicare patients treated with commonly marketed oral anticoagulants for...

New post-hoc analysis of EMPA-REG OUTCOME® examined cost-effectiveness of empagliflozin versus standard of care in a subgroup of people with type 2 diabetes and diabetic kidney disease

Empagliflozin, in addition to standard of care, has the potential to improve economic outcomes for people with type 2 diabetes and established cardiovascular disease who...

Kuwait Finance House Chooses IDEMIA’s Technology for the Country’s First Metal Payment Card

DUBAI, United Arab Emirates–(BUSINESS WIRE)– IDEMIA, the global leader in Augmented Identity, is delighted to announce its partnership with Kuwait Finance House (KFH) to offer...

Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH

FOSTER CITY, Calif. & BAGSVÆRD, Denmark–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) and Novo Nordisk A/S (NASDAQ Copenhagen: NOVO B) today announced that the companies...

Gilead Presents New Data on Viral Hepatitis at the International Liver Congress™ 2019

– Data Demonstrate Role of Gilead HCV Medicines in Difficult–to-Treat Patient Populations and in Real-World Settings – – Latest HBV Data Reinforce Role of Treatment...

C.H. Robinson Expands Its Technology Center in Warsaw, Poland

The 3PL will strengthen its European IT team to drive further development of innovative technologies and provide technology support across markets. AMSTERDAM–(BUSINESS WIRE)– C.H. Robinson...

Gilead Presents New Data in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2019

— New Proof-of-Concept Data for Combination of Investigational FXR Agonist Cilofexor and ACC Inhibitor Firsocostat in NASH — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc....

As Brazil’s New President Jair Bolsonaro Takes the Top Spot as the Most Engaged World Leader on Facebook, Others Pay to Play to Make an Impact on the Platform

BCW Study Finds 50 Leaders Have Paid to Promote Their Posts, Including U.S. President Donald Trump Who Has Promoted More Than 50,000 Posts on Facebook...